
News from drugtopics.com
We’ve assigned a rating of Unknown factuality to drugtopics.com. You can read more about how we’ve determined drugtopics.com’s credibility and reliability as a news source here: https://groundnews.lakegeneva.lib.wi.us/rating-system.
Media Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top drugtopics.com News

US Politics · United StatesU.S. Health Secretary Robert F. Kennedy Jr. on Wednesday named eight new vaccine policy advisers to replace the panel that he abruptly dismissed earlier this week.See the Story
Kennedy names 8 vaccine committee replacements, including COVID shot critic
60% Center coverage: 234 sources

Merck · United StatesThe Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial virus, or RSV, a common but potentially serious seasonal illness.The drug, Enflonsia, is a long-acting monoclonal antibody intended to prevent RSV-related lower respiratory tract disease in newborns and infants entering their first RSV season.RSV is a leading cause of hospitalization among infants in the United States, espec…See the Story
FDA Approves Merck’s Enflonsia to Prevent RSV in Infants
51% Center coverage: 37 sources

Kim Reynolds · Des MoinesPharmacy benefit managers will face new regulations under an Iowa law aimed to prevent pharmacy closures and help financially struggling pharmacies.See the Story
Saving Pharmacies or Raising Drug Costs? Iowa Gov. Kim Reynolds Signs Law Regulating PBMs
67% Center coverage: 21 sources
FDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED) - Enanta Pharma (NASDAQ:ENTA), AbbVie (NYSE:ABBV)
73% Center coverage: 15 sources
Late-Life Mood Disorders May Signal Neurodegenerative Diseases
100% Center coverage: 3 sources